Page last updated: 2024-12-10
ethylenediamine platinum(ii) malonate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 3035205 |
| MeSH ID | M0115452 |
Synonyms (20)
| Synonym |
|---|
| ethylenediammineplatinum(ii) malonate |
| nsc 146068 |
| (ethane-1,2-diamine-n,n')(malonato(2-)-o,o')platinum |
| malpen |
| einecs 255-484-8 |
| platinum, (1,2-ethanediamine-kappan,kappan')(propanedioato(2-)-kappao1,kappao3)-, (sp-4-2)- |
| platinum, (1,2-ethanediamine-n,n')(propanedioato(2-)-o,o')-, (sp-4-2)- |
| platinum (ii), (ethylenediammine)malonato- |
| jm-40 |
| ethylenediamine platinum(ii) malonate |
| unii-9bt36e343a |
| jm 40 |
| malopen |
| 9bt36e343a , |
| (sp-4-2)-(1,2-ethanediamine-.kappa.n1,.kappa.n2)(propanedioato(2-)-.kappa.o1,.kappa.o3)platinum |
| malonatoethylenediamineplatinum(ii) |
| platinum, (1,2-ethanediamine-.kappa.n,.kappa.n')(propanedioato(2-)-.kappa.o1,.kappa.o3)-, (sp-4-2)- |
| platinum, (1,2-ethanediamine-.kappa.n1,.kappa.n2)(propanedioato(2-)-.kappa.o1,.kappa.o3)-, (sp-4-2)- |
| (ethane-1,2-diamine-n,n')[malonato(2-)-o,o']platinum |
| Q27895836 |
Research Excerpts
Pharmacokinetics
| Excerpt | Reference | Relevance |
|---|---|---|
| " Calculated pharmacokinetic parameters (peak concentrations, half-lives, areas under the curve) were compared with the corresponding values in patients at the maximal tolerated dose." | ( Comparative pharmacokinetics of cisplatin and three analogues in mice and humans. Elferink, F; Klein, I; Pinedo, HM; van der Vijgh, WJ; van Hennik, MB; Vermorken, JB; Winograd, B, 1987) | 0.27 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 9 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.15
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.15) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||